Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duygu Ozmadenci

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Seminars in Cell & Developmental Biology|February 8, 2018
Caspase-8 function, and phosphorylation, in cell migrationNadine Keller, Duygu Ozmadenci, Gabriel Ichim, et al.
Cancers|September 13, 2025
Liposomal Doxorubicin, but Not Platinum-Taxane, Supports MHC-II Expression and Immune Maturation in the Ovarian Tumor MicroenvironmentHyojae Lee, Xiao-Lei Chen, Duygu Ozmadenci, et al.
Molecular Biology of the Cell|April 9, 2025
Inducible FAK loss but not FAK inhibition in endothelial cells of PYK2-null mice activates p53 tumor suppressor to prevent tumor growthXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Inducible FAK Deletion but not FAK Inhibition in Endothelial Cells Activates p53 to Suppress Tumor Growth in PYK2-null MiceXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Oncogene|July 17, 2019
Rgnef promotes ovarian tumor progression and confers protection from oxidative stressElizabeth G Kleinschmidt, Nichol L G Miller, Duygu Ozmadenci, et al.
Nature Communications|July 9, 2015
Netrin-1 regulates somatic cell reprogramming and pluripotency maintenanceDuygu Ozmadenci, Olivier Féraud, Suzy Markossian, et al.
Nature Cell Biology|April 2, 2020
Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signallingAurélia Huyghe, Giacomo Furlan, Duygu Ozmadenci, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2022
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axisDuygu Ozmadenci, Jayanth S Shankara Narayanan, Jacob Andrew, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Ovarian Tumor FAK Inhibition Releases Omega-3 Fatty Acids Stimulating GATA6 Peritoneal Macrophage CXCL13 Production Enhancing ImmunotherapyXiao Lei Chen, Kevin M Tharp, Marjaana Ojalill, et al.
Cell Reports|February 25, 2026
FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophagesXiao Lei Chen, Kevin M Tharp, Marjaana Ojalill, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Cell & Developmental Biology|February 8, 2018
Caspase-8 function, and phosphorylation, in cell migrationNadine Keller, Duygu Ozmadenci, Gabriel Ichim, et al.
Cancers|September 13, 2025
Liposomal Doxorubicin, but Not Platinum-Taxane, Supports MHC-II Expression and Immune Maturation in the Ovarian Tumor MicroenvironmentHyojae Lee, Xiao-Lei Chen, Duygu Ozmadenci, et al.
Molecular Biology of the Cell|April 9, 2025
Inducible FAK loss but not FAK inhibition in endothelial cells of PYK2-null mice activates p53 tumor suppressor to prevent tumor growthXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Biorxiv : the Preprint Server for Biology|November 22, 2024
Inducible FAK Deletion but not FAK Inhibition in Endothelial Cells Activates p53 to Suppress Tumor Growth in PYK2-null MiceXiao Lei Chen, Marjaana Ojalill, Christine Jean, et al.
Oncogene|July 17, 2019
Rgnef promotes ovarian tumor progression and confers protection from oxidative stressElizabeth G Kleinschmidt, Nichol L G Miller, Duygu Ozmadenci, et al.
Nature Communications|July 9, 2015
Netrin-1 regulates somatic cell reprogramming and pluripotency maintenanceDuygu Ozmadenci, Olivier Féraud, Suzy Markossian, et al.
Nature Cell Biology|April 2, 2020
Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signallingAurélia Huyghe, Giacomo Furlan, Duygu Ozmadenci, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2022
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axisDuygu Ozmadenci, Jayanth S Shankara Narayanan, Jacob Andrew, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Ovarian Tumor FAK Inhibition Releases Omega-3 Fatty Acids Stimulating GATA6 Peritoneal Macrophage CXCL13 Production Enhancing ImmunotherapyXiao Lei Chen, Kevin M Tharp, Marjaana Ojalill, et al.
Cell Reports|February 25, 2026
FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophagesXiao Lei Chen, Kevin M Tharp, Marjaana Ojalill, et al.
Pageof 2